Cardio-Oncology: What do we know beyond anthracycline cardiotoxicity, Dr. Lili Zhang

Cardio-Oncology: What do we know beyond anthracycline cardiotoxicity? Dr. Lili ZhangПодробнее

Anthracycline Cardiotoxicity: The Role of Cardio-Oncology in ManagementПодробнее

Cardio-Oncology:Mechanisms of Cardiotoxicity and the Evolving Role of EchocardiographyПодробнее

Cardio-oncology A-Z: Late Effects Cardiotoxicity | Dr Neha BansalПодробнее

Advanced Cardiac Imaging Among Patients with Cardiovascular Complications From Cancer ImmunotherapyПодробнее

Cardiovascular Recovery in Anthracycline CardiotoxicityПодробнее

Echocardiography and cardio-oncology; insights and advances, Dr. Marielle Scherrer-Crosbie, MDПодробнее

Cardio-Oncology Impatient ConsultsПодробнее

261. Cardio-Oncology: Cancer Therapy-Related Cardiac Dysfunction (CTRCD) – The Oncologist Perspec...Подробнее

Cardio-Oncology A-Z: CAR-T Cell Cardiotoxicity With Dr Daniel ChenПодробнее

“Past, Present and Future Ways to Detect Cardiotoxicity”Подробнее

Cardiotoxicity of Cancer Therapies: A Review for the Oncology Provider - B. C. Jensen - 20211215Подробнее

Cardio-oncology: Old enemies and new foes - Cardiology Rounds with Dr. Angel Fu, MDПодробнее

Cardiac Dysfunction in Breast Cancer Patients: Monitoring, Diagnosis, and TreatmentПодробнее

Medication to prevent anthracycline cardiotoxicity - IntroПодробнее

CardiotoxicityПодробнее

What is Cardio-OncologyПодробнее

Cardiotoxicity of Cancer Therapy Update - Practical Cardiac Assessment and ManagementПодробнее